aTyr Pharma Class Action Lawsuit Filed, Alleging Securities Fraud.

miércoles, 5 de noviembre de 2025, 10:37 am ET1 min de lectura
ATYR--

A new class-action complaint has been filed against aTyr Pharma and its executives, expanding the alleged class period to November 2024 to September 2025. The lawsuit seeks to represent all investors who bought aTyr Pharma securities during this time, urging those who suffered significant losses to submit their losses and persons with knowledge to contact the firm's attorneys.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios